Ultragenyx Pharmaceutical... (RARE)
Ultragenyx Pharmaceutical Max Pain By Strike
RARE trades at $29.68, 15.2% below the near-term max pain of $35 expiring Aug 15, 2025 (-1 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($20-$35), reflecting growing call interest at higher strikes. Key magnetic zone at 28 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Ultragenyx Pharmaceutical Max Pain By Expiry
Max pain for RARE shows an upward trend from 20 to 35, suggesting bullish positioning in longer-dated options. The 52% spread signals divergent expectations across timeframes. Levels distributed around 29.68. Strong magnetic level at 28 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Aug 15, 2025 | 35 | 5.32 (17.90%) |
Sep 19, 2025 | 30 | 0.32 (1.06%) |
Oct 17, 2025 | 27.5 | -2.18 (-7.36%) |
Nov 21, 2025 | 27.5 | -2.18 (-7.36%) |
Dec 19, 2025 | 35 | 5.32 (17.90%) |
Jan 16, 2026 | 27.5 | -2.18 (-7.36%) |
Feb 20, 2026 | 27.5 | -2.18 (-7.36%) |
Jan 15, 2027 | 20 | -9.68 (-32.63%) |